Parkinsons Articles

New Psychedelic Therapy AKO004 Under Development by Akome

A new psychedelic drug formulation called AKO004 is now under development by Akome Biotech, a wholly owned subsidiary of Core One Labs, as a potential treatment for Parkinson’s disease. The company has filed a provisional

https://parkinsonsnewstoday.com/2021/07/30/akome-developing-psychedelic-parkinsons-therapy-ako004-seeks-us-patent/

Parkinsons News Today

Adhera to Develop MLR-1019 for Easing Parkinson’s Symptoms

Adhera Therapeutics will develop MLR-1019 (armesocarb), a treatment candidate for easing Parkinson’s disease symptoms, following a licensing agreement with Melior Pharmaceuticals II. The therapy is the only one in development that’s designed to treat both

https://parkinsonsnewstoday.com/2021/07/30/adhera-acquires-rights-develop-mlr-1019-easing-parkinsons-symptoms/

Parkinsons News Today

Anxiety: A Silent Symptom of Parkinson’s Disease

Anxiety is the secret poison of Parkinson’s disease. While it is not a symptom many people associate with the condition, many of us still suffer from it. What is anxiety? Anxiety involves feelings of worry,

https://parkinsonsnewstoday.com/2021/07/29/anxiety-silent-symptom-pd/

Parkinsons News Today

Acupuncture as Add-on Therapy May Further Ease Disease Symptoms

People with Parkinson’s disease who combine standard medication with various types of acupuncture treatments may see improvements in their motor function and quality of life, a review study from China suggests. However, its researchers noted

https://parkinsonsnewstoday.com/2021/07/29/acupuncture-plus-standard-treatment-may-ease-parkinsons-motor-symptoms/

Parkinsons News Today

Inhibikase Cleared to Expand Phase 1 IkT-148009 Study

Inhibikase Cleared to Expand Phase 1 IkT-148009 Study

Inhibikase Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to start a Phase 1 clinical trial evaluating its investigational, once-daily, oral medicine IkT-148009 in patients with Parkinson’s disease. The clearance comes after the

read more